Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis
Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis. // Annals of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1665268126000529?dgcid=rss_sd_all
Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis. Annals of Hepatology. https://www.sciencedirect.com/science/article/pii/S1665268126000529?dgcid=rss_sd_all
“Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis.” Annals of Hepatology.
@article{article106742,
title = {Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis},
journal = {Annals of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1665268126000529?dgcid=rss_sd_all}
}